Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?. Expert Opinion on Pharmacotherapy 23:8, pages 917-927.
Read now
Read now
Maria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, Paola Rogliani & Mario Cazzola. (2018) A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety 17:5, pages 509-517.
Read now
Read now
Mario Cazzola, Paola Rogliani, Ermanno Puxeddu, Josuel Ora & Maria Gabriella Matera. (2018) An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert Review of Respiratory Medicine 12:1, pages 43-54.
Read now
Read now
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2016) The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Discovery 11:7, pages 733-744.
Read now
Read now
Maria Gabriella Matera, Vittorio Cardaci, Mario Cazzola & Paola Rogliani. (2015) Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease. Expert Opinion on Drug Safety 14:4, pages 533-541.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani, Barbara Rinaldi & Mario Cazzola. (2015) Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 8:1, pages 35-41.
Read now
Read now
Maria Gabriella Matera, Annalisa Capuano & Mario Cazzola. (2015) Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:1, pages 5-12.
Read now
Read now
Mario Cazzola & Maria Gabriella Matera. (2014) Triple combinations in chronic obstructive pulmonary disease – is three better than two?. Expert Opinion on Pharmacotherapy 15:17, pages 2475-2478.
Read now
Read now
Articles from other publishers (19)
Mario Cazzola, Clive P. Page, Jadwiga A. Wedzicha, Bartolome R. Celli, Antonio Anzueto & Maria Gabriella Matera. (2023) Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD. Respiratory Research 24:1.
Crossref
Crossref
Mario Cazzola & Maria Gabriella Matera. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
712
728
.
Mario Cazzola, Maria Gabriella Matera, Paola Rogliani & Luigino Calzetta. (2021) Comparative studies of dual bronchodilation in COPD. Monaldi Archives for Chest Disease 91:1.
Crossref
Crossref
Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2021) Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?. US Respiratory & Pulmonary Diseases 6:1, pages 31.
Crossref
Crossref
María Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporando nuevas evidencias sobre medicamentos inhalados en la EPOC. Asociación Latinoamericana de Tórax (ALAT) 2019. Archivos de Bronconeumología 56:2, pages 106-113.
Crossref
Crossref
Maria Montes de Oca, Maria Victorina López Varela, Agustín Acuña, Eduardo Schiavi, Alejandro Casas, Antonio Tokumoto, Carlos A. Torres Duque, Alejandra Ramírez-Venegas, Gabriel García, Aquiles Camelier, Miguel Bergna, Mark Cohen, Efraín Sanchez-Angarita, Santiago Guzmán, Karen Czischke, Manuel Barros & Alejandra Rey. (2020) Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019. Archivos de Bronconeumología (English Edition) 56:2, pages 106-113.
Crossref
Crossref
M. G. Matera, C. P. Page, L. Calzetta, P. Rogliani & M. Cazzola. (2019) Pharmacology and Therapeutics of Bronchodilators Revisited. Pharmacological Reviews 72:1, pages 218-252.
Crossref
Crossref
Erika Amore, Maria Letizia Manca, Maria Ferraro, Donatella Valenti, Valeria La Parola, Serena Di Vincenzo, Mark Gjomarkaj, Gaetano Giammona, Maria Luisa Bondì & Elisabetta Pace. (2019) Salmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment. International Journal of Pharmaceutics 562, pages 351-358.
Crossref
Crossref
Paola Rogliani, Josuel Ora, Ermanno Puxeddu, Luigino Calzetta, Francesco Cavalli, Maria Gabriella Matera & Mario Cazzola. (2018) Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study. Pulmonary Pharmacology & Therapeutics 49, pages 20-26.
Crossref
Crossref
Erika Amore, Maria Ferraro, Maria Letizia Manca, Mark Gjomarkaj, Gaetano Giammona, Elisabetta Pace & Maria Luisa Bondì. (2017) Mucoadhesive solid lipid microparticles for controlled release of a corticosteroid in the chronic obstructive pulmonary disease treatment. Nanomedicine 12:19, pages 2287-2302.
Crossref
Crossref
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Davide Lauro, Clive Page & Maria Gabriella Matera. (2017) Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus. Trends in Pharmacological Sciences 38:10, pages 940-951.
Crossref
Crossref
Luigino Calzetta, Maria Gabriella Matera, Fulvio Braido, Marco Contoli, Angelo Corsico, Fabiano Di Marco, Pierachille Santus, Nicola Scichilone, Mario Cazzola & Paola Rogliani. (2017) Withdrawal of inhaled corticosteroids in COPD: A meta-analysis. Pulmonary Pharmacology & Therapeutics 45, pages 148-158.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2017) The Challenges of Precision Medicine in COPD. Molecular Diagnosis & Therapy 21:4, pages 345-355.
Crossref
Crossref
Jutta Beier, Helena Pujol, Beatriz Seoane, Eulalia Jimenez, Carol Astbury, Eric Massana, Sandrine Ruiz & Gonzalo de Miquel. (2016) Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Mario Cazzola & Paola Rogliani. (2016) LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patients. Evidence Based Medicine 21:6, pages 222-222.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
357
381
.
Mario Cazzola & Maria Gabriella Matera. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD
117
129
.
Mario Cazzola, Paola Rogliani & Maria Gabriella Matera. (2015) Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives. Drugs 75:14, pages 1575-1585.
Crossref
Crossref
Adam Bohr & Moritz Beck-Broichsitter. (2015) Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems. Therapeutic Delivery 6:5, pages 621-636.
Crossref
Crossref